An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients

Clinical trial NCT01615601 · COMPLETED

Trial details

NCT number: NCT01615601
Sponsor: Janssen Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Human Immunodeficiency Virus (HIV)

Start date: 2011-10-01
Primary completion: 2013-04-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.